Global 
Sverige 
USA Board of Directors
Stille’s Board consists of the chairman and six board members, of which one member is an employee representative. According to the Articles of Association, the Board of Directors must consist of at least three and no more than seven full members with or without no more than one deputy. According to the Articles of Association, the Board of Directors must have at least four board meetings a year.
Lars Kvarnhem
Chairman of the Board
Year of birth
1972
Elected
2020
Other assignments
Chairman Arcoma, Swevet AB, Swevet Holding AB, Part Production AB, Reison Medical AB and Priego AB and Board Member Cavis Technologies AB.
Professional experience & other information
More than 20 years of experience in global management and business development of companies and business processes within the MedTech industry. Previous roles include CEO and main owner of the medtech company Anmedic AB, , President and CEO for Human Care (publ) and Operational Chairman of the medtech division at Medcap (publ).
Independent of company and its management
Yes
Independent of major shareholders
Yes
Holdings
0 shares
Victor Steien
Member of the Board
Year of birth
1983
Elected
2023
Education
M.Sc. in Economics and Business Administration (Major in Finance), Stockholm School of Economics, Stockholm.
Other assignments
Partner at Impilo and Board Member at Impilo, Pelago Bioscience, VaccinDirekt and Blodtrycksdoktorn.
Professional experience & other information
Part of Impilo's investment team since 2018 and prior to that ten years in Investment Banking at Goldman Sachs (2008-2014) and Morgan Stanley (2014-2018).
Independent of company and its management
Yes
Independent of major shareholders
No
Holdings
Closely associated holdings: 2,056,075 shares
Yonna Olsson
Member of the Board
Year of birth
1963
Elected
2021
Education
M.Sc. in Engineering, MBA, Styrelseakademin.
Other assignments
Board Member and Consultant in primarily medtech
Professional experience & other information
Board Member and Investor. 30 years of experience in international management roles in sales, marketing, strategy and general management in Johnson & Johnson and AstraZeneca among others. Most recently CEO and Area Vice President North Europe at Olympus. Engaged in board assignments since 2010.
Independent of company and its management
Yes
Independent of major shareholders
Yes
Holdings
0 shares
Per Carlsson
Member of the Board
Year of birth
1964
Elected
2023
Education
B.Sc in Finance, University of Uppsala
Other assignments
CFO Camfil Group and Board Member in several of Camfil's subsidiaries
Professional experience & other information
Extensive international experience from position in finance, including roles such as CFO at Electrolux Small Appliances and CFO at Dometic.
Independent of company and its management
Yes
Independent of major shareholders
Yes
Holdings
230 shares
Jens Viebke
Member of the Board
Year of birth
1967
Elected
2024
Education
M.Sc. in Engineering and PhD in polymer technology from the Royal Institute of Technology, Stockholm, and an Executive MBA from the Stockholm School of Economics.
Professional experience & other information
Extensive experience in the healthcare market as a senior executive in strategy, business development, research, and development within several international companies such as GE Healthcare, Pharmacia & Upjohn, and Getinge.
Independent of company and its management
Yes
Independent of major shareholders
Yes
Holdings
0 shares
Sirpa Mäkipää
Member of the Board
(Employee Representative)
Year of birth
1960
Elected
2000
Independent of company and its management
Yes
Independent of major shareholders
Yes
Holdings
0 shares
At each meeting in conjunction with quarterly report, the Managing Director submits an economic and financial report of operations and delivers a monthly report containing important events as well as a summary of economic information to the Board.
Each year, the Board discusses the auditor’s report, which, among other things, details how the company is organised so that accounting, the management of assets and the company’s economic circumstances are controlled in a secure manner.
The Board decides in questions regarding remuneration and other terms of employment for group management. Decisions regarding the principles for remuneration to the Managing Director and other members of group management are made at the AGM.
